NCT00590278View on ClinicalTrials.gov

A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

49

Participants

Timeline

Start Date

August 31, 2002

Conditions

Inoperable or Recurrent Rectal Cancer

Interventions

DRUG

Tomudex

PROCEDURE

Radiotherapy

PROCEDURE

Haematology

PROCEDURE

Biochemistry

Trial Locations (1)

Unknown

Research Site, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY